Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow-to-Debt Ratio
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of ILA721.91 Million could theoretically repay 0% of its total liabilities (ILA32.10 Billion) in one year. See Teva Pharmaceutical Industries Ltd (TEVA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Teva Pharmaceutical Industries Ltd Cash Flow-to-Debt Ratio (1991–2025)
Historical debt coverage capacity for Teva Pharmaceutical Industries Ltd across 35 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Teva Pharmaceutical Industries Ltd.
Annual Cash Flow-to-Debt Ratio for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year debt coverage analysis for Teva Pharmaceutical Industries Ltd. Check TEVA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | ILA3.10 Billion | ILA32.84 Billion | ▲ +154.3% |
| 2024 | 0.04x | ILA1.25 Billion | ILA33.61 Billion | ▼ -4.1% |
| 2023 | 0.04x | ILA1.37 Billion | ILA35.35 Billion | ▼ -14.1% |
| 2022 | 0.05x | ILA1.59 Billion | ILA35.31 Billion | ▲ +105.5% |
| 2021 | 0.02x | ILA798.00 Million | ILA36.42 Billion | ▼ -28.7% |
| 2020 | 0.03x | ILA1.22 Billion | ILA39.58 Billion | ▲ +142.2% |
| 2019 | 0.01x | ILA538.00 Million | ILA42.41 Billion | ▼ -76.7% |
| 2018 | 0.05x | ILA2.45 Billion | ILA44.89 Billion | ▼ -19.4% |
| 2017 | 0.07x | ILA3.51 Billion | ILA51.87 Billion | ▼ -25.1% |
| 2016 | 0.09x | ILA5.22 Billion | ILA57.90 Billion | ▼ -60.4% |
| 2015 | 0.23x | ILA5.54 Billion | ILA24.33 Billion | ▲ +2.5% |
| 2014 | 0.22x | ILA5.13 Billion | ILA23.07 Billion | ▲ +70.8% |
| 2013 | 0.13x | ILA3.24 Billion | ILA24.87 Billion | ▼ -21.0% |
| 2012 | 0.16x | ILA4.57 Billion | ILA27.74 Billion | ▲ +10.8% |
| 2011 | 0.15x | ILA4.13 Billion | ILA27.80 Billion | ▼ -38.7% |
| 2010 | 0.24x | ILA4.14 Billion | ILA17.05 Billion | ▲ +4.6% |
| 2009 | 0.23x | ILA3.37 Billion | ILA14.55 Billion | ▲ +18.7% |
| 2008 | 0.20x | ILA3.23 Billion | ILA16.54 Billion | ▲ +4.0% |
| 2007 | 0.19x | ILA1.81 Billion | ILA9.65 Billion | ▼ -15.2% |
| 2006 | 0.22x | ILA2.06 Billion | ILA9.29 Billion | ▼ -29.9% |
| 2005 | 0.32x | ILA1.37 Billion | ILA4.34 Billion | ▲ +7.1% |
| 2004 | 0.30x | ILA1.25 Billion | ILA4.23 Billion | ▲ +23.4% |
| 2003 | 0.24x | ILA626.60 Million | ILA2.62 Billion | ▲ +88.8% |
| 2002 | 0.13x | ILA353.70 Million | ILA2.79 Billion | ▼ -3.7% |
| 2001 | 0.13x | ILA273.15 Million | ILA2.08 Billion | ▲ +35.2% |
| 2000 | 0.10x | ILA165.63 Million | ILA1.70 Billion | ▼ -38.5% |
| 1999 | 0.16x | ILA153.61 Million | ILA971.72 Million | ▲ +74.8% |
| 1998 | 0.09x | ILA70.20 Million | ILA776.40 Million | ▼ -73.1% |
| 1997 | 0.34x | ILA193.60 Million | ILA575.60 Million | ▲ +3593.0% |
| 1996 | -0.01x | ILA-6.80 Million | ILA706.20 Million | ▼ -104.2% |
| 1995 | 0.23x | ILA105.40 Million | ILA463.70 Million | ▲ +98.5% |
| 1994 | 0.11x | ILA38.20 Million | ILA333.60 Million | ▼ -10.4% |
| 1993 | 0.13x | ILA37.70 Million | ILA295.00 Million | ▲ +0.6% |
| 1992 | 0.13x | ILA28.20 Million | ILA221.90 Million | ▲ +170.5% |
| 1991 | 0.05x | ILA9.10 Million | ILA193.70 Million | — |